Search

everythinglearnresearchcommunity

for

Search:↓

Ruxolitinib helped a patient with alopecia areata regrow hair.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

Dutasteride more effectively lowers DHT levels in men with enlarged prostates than finasteride.

LGD1069 effectively prevents breast tumors in mice without toxicity.

Combining UVB irradiation and anti-CD154 antibody improves hair follicle transplant survival.

Early diagnosis and treatment of EGFR inhibitor-induced folliculitis decalvans can prevent permanent hair loss.

Bleomycin injections in mice cause skin thickening and hair loss.

Methotrexate effectively managed SAPHO syndrome symptoms when other treatments failed.

Researchers created a skin patch that delivers two drugs for treating enlarged prostate, which may improve patient use and dosage control.

The microneedle patches effectively treat allergic conjunctivitis with controlled, sustained release of medication.

Imiquimod may be a better non-surgical treatment for cervical pre-cancer, but its effectiveness for vaginal pre-cancer is unclear, and it has some side effects.

Bimekizumab effectively treated a man's chronic beard hair loss.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Topical calcitriol is safe for preventing hair loss during chemotherapy.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

Both botulinum toxin A and multivitamin mesotherapy effectively treat hair loss, with botulinum toxin A being the better single-session option.

The technique successfully promoted hair growth and skin renewal in mice.

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.

Some blood donors on teratogenic drugs may have unsafe drug levels, suggesting a need for better deferral policies.

Switching to ritlecitinib improves hair regrowth and well-being in severe alopecia areata patients.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

China approved Sinovac's flu vaccine, Japan approved RiUP for female hair loss, and Nippon Kayaku's three cancer drugs.

Mohs micrographic surgery is effective for treating basal cell carcinoma on the eyelid, while radiotherapy has higher recurrence rates, and topical vitamin D3 may reduce and delay BCC formation in mice.

M50054 may help treat hepatitis and hair loss from chemotherapy.

Tofacitinib taken by mouth helps treat hair loss in children.

Combining methotrexate and corticosteroids can effectively regrow hair in severe alopecia areata.

The FDA approved a new Pfizer drug for hair loss in teens.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.